ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 130 filers reported holding ANAPTYSBIO INC in Q1 2019. The put-call ratio across all filers is 0.74 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $1,357,000 | -17.1% | 63,113 | -43.1% | 0.01% | 0.0% |
| Q3 2020 | $1,636,000 | -19.4% | 110,883 | +22.1% | 0.01% | -40.0% |
| Q2 2020 | $2,029,000 | +34.6% | 90,839 | -14.8% | 0.01% | 0.0% |
| Q1 2020 | $1,507,000 | -37.9% | 106,650 | -28.6% | 0.01% | +25.0% |
| Q4 2019 | $2,426,000 | +833.1% | 149,283 | +4096.9% | 0.01% | +700.0% |
| Q1 2019 | $260,000 | -51.5% | 3,557 | -33.8% | 0.00% | -50.0% |
| Q3 2018 | $536,000 | – | 5,374 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,628,678 | $81,462,731 | 11.84% |
| EcoR1 Capital, LLC | 7,521,024 | $233,076,534 | 7.09% |
| 5AM Venture Management, LLC | 357,733 | $11,086,146 | 2.98% |
| Boxer Capital, LLC | 1,300,000 | $40,287,000 | 2.12% |
| Frazier Life Sciences Management, L.P. | 899,700 | $27,881,703 | 1.73% |
| Palo Alto Investors LP | 431,024 | $13,357,434 | 1.14% |
| Logos Global Management LP | 250,000 | $7,747,500 | 0.91% |
| BRAIDWELL LP | 726,122 | $22,502,521 | 0.75% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,161,826 | $36,004,988 | 0.74% |
| Rock Springs Capital Management LP | 576,600 | $17,868,834 | 0.43% |